Patents by Inventor Hugh-Chul Kim

Hugh-Chul Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for isolating and culturing multipotent progenitor cells from umbilical cord blood
    Patent number: 7816137
    Abstract: Since the multipotent progenitor/stem cells isolated and cultured from the cord blood-derived mononuclear cells according to the method of the present invention are capable of differentiating into several types of cells including neurons, osteoblasts, myoblasts, endothelial cells, hepatocytes and dendritic cells, they can be effectively used for a cell therapy, a cell restoration technique or an organ production.
    Type: Grant
    Filed: January 31, 2005
    Date of Patent: October 19, 2010
    Assignees: Lifecord Inc.
    Inventors: Myoung Woo Lee, Young Jin Kim, Jeong Eun Choi, Mal Sook Yang, Young Joon Moon, Sun Kyung Kim, Hugh Chul Kim, Joon Seong Park, In Keun Jang
  • CD8?lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
    Patent number: 7390658
    Abstract: Lymphoid dendritic cells with immunophenotype CD8?+ can be produced by a method which comprises culturing human hematopoietic stem cells in a medium containing GM-CSF, followed by culturing in a medium containing IFN-?, the lymphoid dendritic cells being useful in various immunotherapies.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: June 24, 2008
    Assignees: Lifecord, Inc., FCB-Pharmicell Co., Ltd.
    Inventors: Hyun-Soo Kim, Kyung-Bock Lee, Hugh-Chul Kim
  • Cd8alphadendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
    Publication number: 20040132185
    Abstract: Lymphoid dendritic cells with an immunophenotype of CD8&agr;+ can be produced by a method which comprises culturing human hematopoietic stem cells in a medium containing GM-CSF, followed by culturing in a medium containing IFN-&Ugr;, said cells being useful in various immunotherapies.
    Type: Application
    Filed: February 19, 2004
    Publication date: July 8, 2004
    Inventors: Hyun-Soo Kim, Kyung-Bock Lee, Hugh-Chul Kim